# Pemvidutide IMPACT study record updated

> ClinicalTrials.gov lists a completed Pemvidutide study sponsored by Altimmune, Inc.

- Evidence object: `story:pemvidutide-impact-study-updated:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-05-18
- Source checked: 2026-07-22
- Published by PeptideScanner: 2026-07-22
- Story landing page: https://peptidescanner.com/stories/pemvidutide-impact-study-updated/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pemvidutide-impact-study-updated-v1.json
- Content SHA-256: `6797214808253b2a7f79285dd5683501825712d5c2f413234860b24bd10306cd`

## Claims and source pins

### Headline

Pemvidutide IMPACT study record updated ([`ctg-nct05989711-v10`](#source-ctg-nct05989711-v10))

### Summary

ClinicalTrials.gov lists a completed Pemvidutide study sponsored by Altimmune, Inc. ([`ctg-nct05989711-v10`](#source-ctg-nct05989711-v10))

### Paragraph 1

ClinicalTrials.gov lists the NCT05989711 record under Altimmune, Inc. Its overall recruitment status was shown as completed when PeptideScanner reviewed the record. ([`ctg-nct05989711-v10`](#source-ctg-nct05989711-v10))

### Paragraph 2

The registry shows 2026-05-18 as its latest posted update date. This update reports the registry record and does not establish safety, effectiveness, or a trial outcome. ([`ctg-nct05989711-v10`](#source-ctg-nct05989711-v10))

## Sources

<a id="source-ctg-nct05989711-v10"></a>
- **IMPACT: Pemvidutide in Participants With NASH · record history version 10 · last update posted 2026-05-18** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05989711?a=10&tab=history) (`ctg-nct05989711-v10`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Pemvidutide IMPACT study record updated." Version 1, published 2026-07-22. https://peptidescanner.com/evidence/v1/objects/pemvidutide-impact-study-updated-v1.json SHA-256: 6797214808253b2a7f79285dd5683501825712d5c2f413234860b24bd10306cd.